Latham & Watkins advised Harmony Biosciences, while Paul Hastings LLP advised J.P. Morgan as the sole book-running manager in the offering. Harmony Biosciences Holdings, Inc. (Nasdaq:...
Harmony Biosciences’ Common Stock Offering
Harmony Biosciences Holdings’ Acquisition of Zynerba Pharmaceuticals
Hogan Lovells acted as legal counsel for Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies...